Genomic Valley Biote News
AllNewsAnnouncementRecos
BSE LIVE
Change:
Volume:
Open:
Prv. Close:
Bid:
()
Offer:
()
NSE LIVE
Change:
Volume:
Open:
Prv. Close:
Bid:
()
Offer:
()
Genomic Valley Biotech Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
| AnnouncementThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Yogesh Agrawal & Parul Agrawal
Genomic Valley Biotech Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
| AnnouncementThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Yogesh Agrawal
Genomic Valley Biotech Submission Of Un-Audited Standalone Financial Results For The Quarter Ended On June 30, 2024
| AnnouncementPlease find enclosed herewith the Un- Audited Standalone financial result for the quarter ended on June 30,2024 .
Genomic Valley Biotech Board Meeting Intimation for Intimation Regarding Holding Of Board Meeting On 29Th July, 2024 To Consider Un-Audited Fin...
| AnnouncementGenomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 ,inter alia, to consider and approve Intimation regarding Holding of Board Meeting on 29th July, 2024 to consider Un-Audited Financial Results for the quarter ended June 30, 2024
Genomic Valley Biotech Non-Applicability Of Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
| AnnouncementNon applicability of Reg 23(9) is enclosed herewith
Genomic Valley Biotech Board Meeting Outcome for Outcome Of Board Meeting
| AnnouncementOutcome of the Board Meeting is enclosed.
Genomic Valley Biotech Compliance Certificate Under Reg 40(10) Of LODR Reg.
| AnnouncementCompliance certificate under Reg 40(10) of LODR Reg
Genomic Valley Biotech Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
| AnnouncementCertificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Genomic Valley Biotech Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementIssue of Duplicate Share Certificate
Genomic Valley Biotech Announcement under Regulation 30 (LODR)-Newspaper Publication
| AnnouncementNewspaper Publication of Un-Audited Financial Results for the quarter and nine months ended 31.12.2023
Genomic Valley Biotech Announcement under Regulation 30 (LODR)-Change in Directorate
| AnnouncementChange in Directorate
Genomic Valley Biotech Results-Financial Results For 31.12.2023
| AnnouncementResults - Financial Results for 31.12.2023
Genomic Valley Biotech Announcement under Regulation 30 (LODR)-Newspaper Publication
| AnnouncementNewspaper Advertisement of Notice of Board Meeting
Genomic Valley Biotech Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
| AnnouncementCertificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Genomic Valley Biotech Announcement under Regulation 30 (LODR)-Resignation of Director
| AnnouncementResignation of Non-Executive Independent Director of the Company